Anika Therapeutics, Inc. - ANIK

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Jan 27, 2026 SCHEDULE 13D/A 4.3% View
Jan 08, 2026 SCHEDULE 13G/A Trigran Investments, Inc. 1.2% 168,400 View
Jan 08, 2026 SCHEDULE 13G/A Douglas T. Granat 1.2% 168,400 View
Jan 08, 2026 SCHEDULE 13G/A Lawrence A. Oberman 1.2% 168,400 View
Jan 08, 2026 SCHEDULE 13G/A Steven G. Simon 1.2% 168,400 View
Jan 08, 2026 SCHEDULE 13G/A Bradley F. Simon 1.2% 168,400 View
Jan 08, 2026 SCHEDULE 13G/A Steven R. Monieson 1.2% 168,400 View
Nov 21, 2025 SCHEDULE 13D/A 2.0% View
Nov 07, 2025 SCHEDULE 13G/A Trigran Investments, Inc. 11.2% 1,621,215 View
Nov 07, 2025 SCHEDULE 13G/A Douglas T. Granat 11.2% 1,621,215 View
Nov 07, 2025 SCHEDULE 13G/A Lawrence A. Oberman 11.2% 1,621,215 View
Nov 07, 2025 SCHEDULE 13G/A Steven G. Simon 11.2% 1,621,215 View
Nov 07, 2025 SCHEDULE 13G/A Bradley F. Simon 11.2% 1,621,215 View
Nov 07, 2025 SCHEDULE 13G/A Steven R. Monieson 11.2% 1,621,215 View
Oct 17, 2025 SCHEDULE 13G BlackRock Portfolio Management LLC 5.5% 793,359 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.